Share on StockTwits

Vectura Group (LON:VEC)‘s stock had its “buy” rating reiterated by analysts at FinnCap in a research report issued to clients and investors on Thursday, American Banking News reports. They currently have a GBX 180 ($2.95) target price on the stock. FinnCap’s price target would suggest a potential upside of 16.88% from the company’s current price.

A number of other analysts have also recently weighed in on VEC. Analysts at JPMorgan Chase & Co. reiterated an “overweight” rating on shares of Vectura Group in a research note on Wednesday, February 5th. Finally, analysts at N+1 Singer raised their price target on shares of Vectura Group from GBX 97 ($1.59) to GBX 110 ($1.80) in a research note on Tuesday, January 14th. They now have a “sell” rating on the stock. Two research analysts have rated the stock with a sell rating and eight have issued a buy rating to the stock. The stock has a consensus rating of “Buy” and a consensus target price of GBX 148.88 ($2.44).

Shares of Vectura Group (LON:VEC) traded down 0.96% during mid-day trading on Thursday, hitting GBX 154.00. 286,763 shares of the company’s stock traded hands. Vectura Group has a 1-year low of GBX 76.00 and a 1-year high of GBX 165.00. The stock’s 50-day moving average is GBX 152.2 and its 200-day moving average is GBX 120.2. The company’s market cap is £522.3 million.

Vectura Group plc (LON:VEC) is a developer of therapies principally for the treatment of respiratory diseases.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.